NIAID – Chemistry Center for CARB
CC4CARB is a chemistry center synthesizing novel scaffolds for Gram-negative drug discovery.
CC4CARB is a complimentary synthesis on approved scaffolds.
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial compound/strategy
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Research
- Development
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Institute
- Company
- Academia
- NGO
- Government
Partnering:
- Co-develop
- Outsource
- License
- Joint Venture
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- North America
- South America
- Eurasia
- Africa
- Oceania
Submitted scaffold proposals will be confidential; however, compounds synthesized as a result of an accepted proposal will be made public as part of the CC4CARB collection.
CC4CARB is a center focused on the synthesis & delivery of rationally designed libraries for use in Gram-negative antibacterial drug discovery.
The ultimate objective of CC4CARB is to combine these libraries and create a large collection of chemical matter specifically targeting Gram-negative antimicrobial drug discovery.